Once-Daily ORAVIG now available

  • ORAVIG® FEATURES – Once Daily Dosing, Flavorless, Odorless with an Innovative Buccal Delivery Technology.
  • ORAVIG® is the First and Only Miconazole antifungal option available orally in a buccal tablet.  ORAVIG® is indicated for the local treatment of oropharyngeal candidiasis in adults (OPC).
  • It is estimated that millions of prescriptions are generated for antifungal products to treat OPC Praelia’s sales force commenced sales activity in Dec 2012.
  • Product is now available for shipping.
  • Praelia’s sales force of 100+ skilled reps is targeting high decile oncology supportive care physicians in all of the National Metro areas.
  • Praelia will utilize a tele sales team to e-detail the physicians in the surrounding Metro areas nationally.
  • Praelia is commitment to working closely with Managed Care partners to maximize reimbursement.
  • Praelia is utilizing a discount copay card to reduce patient out of pocket cost.
  • Praelia Pharmaceuticals has dedicated a vast amount of resources towards introducing Oravig.

NDC 43288-250-14 / Capital Wholesale Drug Co. order number 300200


See Full Prescribing Information

This entry was posted in Capital News, Weekly Specials. Bookmark the permalink.

Comments are closed.